Aterian (ATER) traded up 6.26 % during a 24 hours period ending at 11:40 PM Central Europe on Tuesday 27th. One Aterian stock can currently be bought for about USD 0.68 on popular exchanges. Current supply of Aterian stocks is 16.3 mn. Aterian has a current market capitalization of USD 10.1 mn and approximately USD 80.6 k worth of Aterian was traded on exchanges in the last 24 hours. Since last month end, Aterian has traded 2 % up. Simple moving average of last 200 days is at USD 0.78. The highest price of past 52 weeks was recorded at USD 1.87 on 04/28/2026. 52 weeks low was at USD 0.35 on 07/28/2026.

Here is how related stocks have performed in the past 24 hours:

  • Aeon Biopharma (AEON) traded flat 0 % and now trades at USD 0.25. Aeon Biopharma has a market capitalisation of USD 12 mn. AEON Biopharma, Inc. filed a definitive proxy statement on 26 October 2026, announcing a special meeting of shareholders scheduled for 15 December 2026. The board will seek approval for four items: a reverse‑stock‑split authority that would allow the company to combine shares at a board‑chosen ratio of 1‑for‑2 to 1‑for‑100; an amendment to the company’s incentive award plan to include pre‑funded warrants in the calculation of fully‑diluted shares; an amendment to the employee stock purchase plan with a similar adjustment; and a procedural proposal to adjourn the meeting if necessary. The proxy statement notes that the reverse‑split authority is subject to compliance with exchange rules, including cumulative‑ratio limits, and that implementation would be optional and limited to a twelve‑month window. The filing does not indicate any immediate change in share count or capital structure beyond the potential split, nor does it mention new financing or share issuances. The document provides guidance on voting procedures, record‑date requirements, and the board’s recommendation for a “for” vote on each proposal. No additional corporate actions or market‑price expectations are disclosed beyond the procedural framework set out for the upcoming shareholder meeting.

  • Mkd Tech (MKDW) traded up 20.81 % and now trades at USD 0.26. Mkd Tech has a market capitalisation of USD 11.9 mn.

  • Bloomia (TULP) traded down -4.17 % and now trades at USD 2.26. Current market capitalisation for Bloomia is USD 11.6 mn.

  • Biofrontera (BFRI) traded up 4.18 % and now trades at USD 0.84. Current market capitalisation for Biofrontera is USD 11.7 mn.

  • Lipocine (LPCN) traded up 0.69 % and now trades at USD 1.46. Lipocine has a market capitalisation of USD 11.9 mn.

About Aterian

Aterian, Inc. is a consumer product platform operating in the Consumer Discretionary sector, offering a diverse range of products including home and kitchen appliances, health and wellness, beauty, and consumer electronics. The company serves customers globally, with its official website accessible at www.aterian.io . Aterian, Inc. is Nasdaq-listed.